Response to Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial".

Autor: Miller BS; Division of Pediatric Endocrinology, University of Minnesota Masonic Children's Hospital, Minneapolis, MN 55454, USA., Blair JC; Department of Endocrinology, Alder Hey Children's NHS Foundation Trust, Liverpool L14 5AB, UK., Rasmussen MH; Novo Nordisk A/S, Søborg 2860, Denmark., Maniatis A; Rocky Mountain Pediatric Endocrinology, Centennial, CO 80112, USA., Kildemoes RJ; Novo Nordisk A/S, Søborg 2860, Denmark., Mori J; Division of Pediatric Endocrinology and Metabolism, Children's Medical Center, Osaka City General Hospital, Osaka 534-0021, Japan., Polak M; Service d'Endocrinologie, Gynécologie et Diabétologie Pédiatriques, Hôpital Universitaire Necker Enfants Malades Paris, Assistance Publique-Hôpitaux de Paris, Paris 75015, France., Bang RB; Novo Nordisk A/S, Aalborg 9220, Denmark., Böttcher V; Division of Pediatric Endocrinology and Metabolism, MVZ Endokrinologikum Frankfurt am Main, Frankfurt 60596, Germany., Stagi S; Department of Health Sciences, University of Florence, Anna Meyer Children's University Hospital, Florence 50139, Italy., Horikawa R; Division of Endocrinology and Metabolism, National Center for Child Health and Development, Tokyo 157-0074, Japan.
Jazyk: angličtina
Zdroj: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2023 Jul 14; Vol. 108 (8), pp. e647-e648.
DOI: 10.1210/clinem/dgad095
Databáze: MEDLINE